Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder

Yehuda Senecky; Danielle Lobel; Gary W Diamond; Raphael Weitz; Dov Inbar

doi:10.1016/s0887-8994(02)00429-0

Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder

Pediatr Neurol. 2002 Sep;27(3):224-6. doi: 10.1016/s0887-8994(02)00429-0.

Authors

Yehuda Senecky¹, Danielle Lobel, Gary W Diamond, Raphael Weitz, Dov Inbar

Affiliation

¹ Child Development and Rehabilitation Institute, Petah-Tikva, Israel.

PMID: 12393134
DOI: 10.1016/s0887-8994(02)00429-0

Abstract

We report a case of orofacial dyskinesia in a 6-year-old female with attention-deficit-hyperactivity disorder who received a low dose of methylphenidate. The orofacial dyskinesia appeared immediately and subsided rapidly on the same day in an "on-off" fashion and on 3 separate days when methylphenidate was taken. To our knowledge this particular side effect has not been described previously and might represent an unusual type of brain response or sensitivity.

Publication types

Case Reports

MeSH terms

Attention Deficit Disorder with Hyperactivity / drug therapy*
Central Nervous System Stimulants / adverse effects*
Central Nervous System Stimulants / therapeutic use
Child
Dose-Response Relationship, Drug
Dyskinesia, Drug-Induced / diagnosis
Dyskinesia, Drug-Induced / etiology*
Female
Humans
Methylphenidate / adverse effects*
Methylphenidate / therapeutic use
Neurologic Examination / drug effects

Substances

Central Nervous System Stimulants
Methylphenidate